V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310011690 | 310009740 | 1.61 | 55.6 | Curative (C) | 2019-10-17 | 2019-12-20 | Brentuximab | 02 | N | 310018245 | BRENTUXIMAB |
| 310011691 | 310004590 | 1.74 | 16.8 | Curative (C) | 2016-01-03 | 2016-01-03 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 310018278 | GEMCITABINE |
| 310011692 | 310010702 | null | 75.6 | Disease modification (D) | 2017-11-14 | 2017-11-24 | Bortezomib + Prednisolone + CYCLOPHOSPHAMIDE + Prednisolone + DOXORUBICIN + Prednisolone + Prednisolone + RITUXIMAB + Prednisolone + VINCRISTINE | 02 | N | 310018292 | NOT MATCHED |
| 310011693 | 310011252 | 1.67 | null | Disease modification (D) | 2018-08-13 | 2018-08-13 | Brentuximab | 02 | N | 310018383 | BRENTUXIMAB |
| 310011694 | 310004624 | 1.57 | 66.9 | Disease modification (D) | 2018-08-19 | 2018-09-02 | IVE | 02 | N | 310018446 | IVE |
| 310011695 | 310004632 | 1.57 | 84 | Palliative (P) | 2016-01-01 | 2016-01-08 | Carboplatin + Liposomal Doxorubicin | 2 | N | 310018465 | CARBOPLATIN + LIPOSOMAL DOX |
| 310011696 | 310004637 | 1.59 | 92.7 | Curative (C) | null | 2013-11-30 | IVE | N | N | 310018467 | IVE |
| 310011697 | 310007976 | 1.62 | 70 | Palliative (P) | 2020-01-05 | 2020-01-18 | Brentuximab Vedotin | N | N | 310018478 | BRENTUXIMAB |
| 310011698 | 310004652 | 1.68 | 52.6 | Palliative (P) | null | 2017-06-19 | GEM-P | Y | N | 310018504 | GEMCITABINE + PACLITAXEL |
| 310011699 | 310004672 | null | 74.8 | Disease modification (D) | 2019-12-03 | 2019-12-06 | Rituximab | 02 | N | 310018537 | RITUXIMAB |
| 310011700 | 310004709 | 1.71 | 57 | Palliative (P) | 2020-03-10 | 2020-03-10 | Ipilimumab | 2 | N | 310018650 | IPILIMUMAB |
| 310011701 | 310004731 | null | 58.7 | Palliative (P) | 2014-09-27 | 2015-04-23 | Ipilimumab | N | N | 310018701 | IPILIMUMAB |
| 310011702 | 310004776 | 1.81 | 29.7 | Curative (C) | 2019-03-30 | 2019-03-31 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 310018871 | BEXAROTENE |
| 310011703 | 310004783 | 1.85 | 54.2 | Disease modification (D) | 2018-12-23 | 2019-06-02 | Docetaxel | 2 | N | 310018888 | DOCETAXEL |
| 310011704 | 310004811 | 1.7 | null | Curative (C) | 2017-01-31 | 2017-03-06 | Cisplatin | N | null | 310018968 | CISPLATIN |
| 310011705 | 310004822 | 1.85 | 89.8 | Palliative (P) | 2015-06-04 | 2015-07-17 | ALL UKALL2011 Cap Int Maint C PAsp | null | null | 310018998 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310011706 | 310004834 | 1.69 | 62 | Palliative (P) | 2018-03-16 | 2018-03-17 | Methotrexate intrathecal | 02 | N | 310019038 | METHOTREXATE INTRATHECAL |
| 310011707 | 310008097 | 1.69 | 58.2 | Palliative (P) | 2015-01-12 | 2015-05-19 | Cisplatin + Radiotherapy | 2 | N | 310019139 | CISPLATIN + RT |
| 310011708 | 310004910 | 1.66 | null | Palliative (P) | 2016-09-11 | 2017-01-06 | Bevacizumab+Carbo+Pacliaxel | 2 | N | 310019366 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310011709 | 310004912 | 1.84 | 28.5 | Curative (C) | 2013-12-14 | 2013-12-23 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | N | N | 310019371 | DOCETAXEL + GEMCITABINE |
| 310011710 | 310008122 | 1.56 | 96 | Neo-adjuvant (N) | 2018-01-21 | 2018-01-25 | Rituximab | 2 | null | 310019376 | RITUXIMAB |
| 310011711 | 310004921 | 1.68 | 71.2 | Not known (9) | 2017-03-15 | 2017-03-28 | Docetaxel+Gemcitabine (no prior RT) | N | N | 310019388 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310011712 | 310004934 | 1.62 | null | Palliative (P) | 2016-06-19 | 2016-09-24 | CYCLOPHOSPHAMIDE | N | N | 310019457 | CYCLOPHOSPHAMIDE |
| 310011713 | 310004948 | null | 69.65 | null | 2015-08-30 | 2015-09-03 | Docetaxel 100mg/m2 (21 day) | N | N | 310019473 | DOCETAXEL |
| 310011714 | 310004957 | 1.88 | 78 | null | 2017-05-26 | 2018-07-22 | Cisplatin 100 + RT(H&N) 1 day | N | N | 310019507 | CISPLATIN + RT |
| 310011715 | 310008146 | 1.59 | 96 | Curative (C) | 2018-02-16 | 2018-03-12 | Docetaxel 75mg/m2 (21 day) | N | null | 310019511 | DOCETAXEL |
| 310011717 | 310004971 | 1.74 | null | Palliative (P) | 2016-08-28 | 2016-09-28 | EOX | N | Y | 310019558 | DOXORUBICIN |
| 310011718 | 310004984 | 1.76 | 98 | Palliative (P) | 2016-01-07 | 2016-02-09 | DOXORUBICIN | N | N | 310019617 | PEG INTERFERON |
| 310011719 | 310008171 | 1.48 | 46.8 | Not known (9) | 2015-05-05 | 2015-05-30 | Temozolomide 200mg/m2 | null | null | 310019675 | OXALIPLATIN + MDG |
| 310011720 | 310005000 | 1.67 | 57 | Palliative (P) | 2014-11-27 | 2015-01-30 | Trabectedin | N | N | 310019677 | CVP R |
| 310011722 | 310005012 | 1.54 | 48.2 | Curative (C) | 2017-06-22 | 2017-07-08 | CARBOPLATIN + FLUOROURACIL | N | N | 310019697 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 310011723 | 310005025 | null | 74.3 | Disease modification (D) | null | 2015-05-25 | Cetuximab 7 day (>Cycle 2) | 2 | null | 310019750 | DOXORUBICIN |
| 310011724 | 310011284 | 1.65 | 68.7 | Curative (C) | 2016-08-09 | 2016-08-19 | DOXORUBICIN | N | N | 310019847 | ATG |
| 310011725 | 310005054 | null | 56.7 | Palliative (P) | 2018-02-18 | 2018-04-09 | CYTARABINE + METHOTREXATE | Y | N | 310019894 | ICE |
| 310011726 | 310005083 | 1.83 | 65.3 | Curative (C) | 2019-09-08 | 2019-09-08 | DOXORUBICIN | 02 | null | 310019991 | CARBOPLATIN + PEMETREXED |
| 310011727 | 310005111 | 1.5 | 87.2 | Palliative (P) | 2017-07-11 | 2017-07-20 | Atezolizumab | N | N | 310020124 | ECX |
| 310011728 | 310005124 | 1.62 | 43.1 | Palliative (P) | 2017-02-18 | 2017-02-21 | CETUXIMAB | N | N | 310020170 | MITOXANTRONE + PACLITAXEL |
| 310011729 | 310009904 | 1.7 | 112 | Palliative (P) | 2014-02-11 | 2014-06-02 | Cyclophosphamide + Topotecan | N | N | 310023229 | POMALIDOMIDE |
| 310011730 | 310008298 | 1.63 | 74.6 | Curative (C) | 2016-12-06 | 2016-12-07 | Bevacizumab+Carbo+Gemcitabine | 2 | N | 310024324 | ERIBULIN |
| 310011731 | 310005251 | 1.63 | 117 | Palliative (P) | 2017-08-30 | 2018-05-06 | Cetuximab 7 day (>Cycle 2) | 02 | N | 310024543 | BEVACIZUMAB + CARBO |
| 310011732 | 310005265 | 1.61 | 53.7 | Palliative (P) | 2019-02-01 | 2019-02-08 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | 310024633 | METHOTREXATE |
| 310011733 | 310011750 | 1.89 | 60.8 | Palliative (P) | 2015-10-18 | 2015-12-02 | Dacarbazine | null | null | 310024934 | BORTEZOMIB |
| 310011734 | 310005294 | 1.65 | 59.7 | Curative (C) | 2015-07-06 | 2016-01-27 | Gemcitabine + Oxaliplatin | N | N | 310024937 | CAV |
| 310011735 | 310005296 | 1.71 | 59.3 | Palliative (P) | 2018-04-15 | 2018-12-11 | ALL UKALL 2011 HD MtxA (Protocol M) | N | N | 310024973 | ATG + BUSULFAN + FLUDARABINE + THIOTEPA |
| 310011736 | 310005330 | null | 81 | Palliative (P) | 2012-07-26 | 2014-05-13 | IBRUTINIB | N | N | 310025291 | REGORAFENIB |
| 310011737 | 310005339 | 1.96 | 104.8 | Curative (C) | 2016-11-21 | 2016-12-09 | NIVOLUMAB | N | N | 310025341 | GDCVP |
| 310011738 | 310005343 | 1.61 | 10.3 | Palliative (P) | 2017-01-06 | 2017-01-13 | Capecitabine + Cisplatin | 02 | N | 310025360 | CARBOPLATIN + PACLITAXEL + RT |
| 310011739 | 310005366 | 1.71 | 71 | Palliative (P) | 2017-01-13 | 2017-01-13 | DABRAFENIB | N | N | 310025608 | CETUXIMAB + RT |
| 310011740 | 310005385 | null | 76.9 | Palliative (P) | null | 2016-10-21 | Oxaliplatin + Modified de Gramont | N | N | 310025710 | LENALIDOMIDE |
| 310011741 | 310008371 | 1.73 | 58 | Curative (C) | 2015-09-05 | 2015-09-13 | Olaparib | N | N | 310025719 | CAPECITABINE + CISPLATIN |